Summary Info
No Summary

NAV Details

NAV Date : 25-Feb-13
NAV [Rs.] : 11.0
Buy/Resale Price [Rs.] : 0.00
Sell/Repurchase Price [Rs.] : 0.00
Entry Load % : Nil
Exit Load % : Nil

NAV Chart

Graph: 1m |   3m |   6m |   1y |   3y
No Chart

Performance(%)

* returns above 1 yr. are annualized

No Performance

Latest Payouts

  Dividends Bonus
Ratio NA NA
Date NA NA

Investment Details

Tax Benefits : NA
Min. Investment(Rs.) : 5,000.00
Increm.Investment(Rs.) : 0.00

In & Out

In
Name of the Company No of shares
No fresh investments made in
Out
Name of the Company No of shares
No investments sold out

Fund Holdings

As on 31-Mar-2013

Asset TypeInstrument NameIndustryNet Assets
(%)		No of SharesMkt Value
(Cr.)
Money Market Investments
Certificate of Depositsc d axis bank ltd.A1+24.71,570,000,000156.1
Certificate of Depositsc d icici bank ltdA1+23.61,500,000,000149.2
Certificate of Depositsc d idbi bank ltd.A1+23.61,500,000,000149.2
Certificate of Depositsc d federal bank ltd.A1+11.8750,000,00074.6
Certificate of Depositsc d andhra bankA1+7.9500,000,00049.7
Certificate of Depositsc d corporation bankA1+7.9500,000,00049.7
Cash & Cash Equivalent
Net CA & Othersnet current assets-/-0.7NA4.2

My Watchlist


Schemes NAV(Rs.)
No Fund

Key Information

Fund House: 
Incorporation Date : 
Total Assets Managed (Cr.) : 
Trustee/s : 
Chairman : 
CEO / MD : 
CIO : 
President : 
Director/s : 
Compliance Officer/s : 
Investor Service Officer/s : 
Fund Manager/s : 

Other Information

Auditors : 
Registered Office : 
Contact Nos : 
Fax : 
Email :
Website : 

Fund Manager Speak

Tushar Pradhan, CIO, HSBC Mutual Fund
“Our research shows that a disciplined approach to buying companies that look attractive on this matrix provides significant longer term outperformance.”..
Vikaas Sachdeva, CEO, Edelweiss Asset Management Ltd
Kaushik Dani, Head of Equity, Peerless Funds Management Company
View all Fund Manager Speak >>

IIFL Blogs

Nirmal Jain
RBI, don't write off brokers
Broking is no less qualified than others to be eligible for a banking license, based on merits.
Amar Ambani
Inorganic is the Tonic for Indian Pharma
Indian Players in the Pharma industry with good hold over the domestic market and the wherewithal to cash in on inorganic growth opportunities are likely to rule the roost in the coming years